Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice
- DOI
- 10.1007/s10549-026-08112-2
- Published
- 2026-10-26
- Container
- Breast Cancer Research and Treatment
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-026-08112-2,
title = {Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice},
author = {Claire E. Smith and Avina Rami and Tianyu Li and Nabihah Tayob and Pooja Patel and Harold J. Burstein and Sandra McAllister and Rachel Abelman and Rachel A. Freedman},
year = {2026},
journal = {Breast Cancer Research and Treatment},
doi = {10.1007/s10549-026-08112-2},
url = {https://doi.org/10.1007/s10549-026-08112-2}
}RIS
TY - JOUR TI - Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice AU - Claire E. Smith AU - Avina Rami AU - Tianyu Li AU - Nabihah Tayob AU - Pooja Patel AU - Harold J. Burstein AU - Sandra McAllister AU - Rachel Abelman AU - Rachel A. Freedman PY - 2026 JO - Breast Cancer Research and Treatment DO - 10.1007/s10549-026-08112-2 UR - https://doi.org/10.1007/s10549-026-08112-2 ER -
APA
Smith, C. E., Rami, A., Li, T., Tayob, N., Patel, P., Burstein, H. J., McAllister, S., Abelman, R., & Freedman, R. A. (2026). Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08112-2
Source records
- crossref · retrieved 2026-11-10T14:23:53.762Z